Literature DB >> 9721239

The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors.

J Schaefer-Klein1, I Givol, E V Barsov, J M Whitcomb, M VanBrocklin, D N Foster, M J Federspiel, S H Hughes.   

Abstract

The lack of a well-behaved permanent, adherent, nontransformed chicken cell line has made some experiments with avian leukosis-sarcoma viruses (ASLV) and vectors considerably more difficult. The EV-O-derived line, DF-1, supports the efficient replication of subgroups (A), (B), and (C) ASLV, as well as amphotrophic murine leukemia virus and an ASLV-derived vector that has its env gene derived from the env gene from an amphotrophic murine leukemia virus. The cell line responds appropriately to the expression of a transforming oncogene (v-myc) to a growth suppressor gene [p21(waf1)] and can be sorted (using FACS) if infected by an ASLV vector that expresses GFP. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721239     DOI: 10.1006/viro.1998.9291

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  107 in total

1.  Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.

Authors:  V B Pinto; S Prasad; J Yewdell; J Bennink; S H Hughes
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Regulated gene expression in the chicken embryo by using replication-competent retroviral vectors.

Authors:  Noboru Sato; Kenji Matsuda; Chie Sakuma; Douglas N Foster; Ronald W Oppenheim; Hiroyuki Yaginuma
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.

Authors:  S Snitkovsky; T M Niederman; B S Carter; R C Mulligan; J A Young
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector.

Authors:  Jennifer L Bromberg-White; Craig P Webb; Veronique S Patacsil; Cindy K Miranti; Bart O Williams; Sheri L Holmen
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.

Authors:  Marc C Johnson; Jared L Spidel; Danso Ako-Adjei; John W Wills; Volker M Vogt
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

8.  Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.

Authors:  Deborah C Melder; V Shane Pankratz; Mark J Federspiel
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Identification of avian RIG-I responsive genes during influenza infection.

Authors:  Megan R W Barber; Jerry R Aldridge; Ximena Fleming-Canepa; Yong-Dong Wang; Robert G Webster; Katharine E Magor
Journal:  Mol Immunol       Date:  2012-12-04       Impact factor: 4.407

10.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.